IMPORTANT INFORMATION ABOUT INSPACE

The InSpace Implant is indicated for the treatment of patients with massive, irreparable full-thickness torn rotator cuff tendons due to trauma or degradation with mild to moderate gleno-humeral osteoarthritis in patients greater than or equal to 65 years of age whose clinical conditions would benefit from treatment with a shorter surgical time compared to partial rotator cuff repair.

The InSpace Implant is not appropriate for patients with certain types of infections, known or suspected allegories to the implant and/or instrument materials, or children.

The following information provided is based on data collected in the US Pivotal Clinical Study. There is evidence of increased risk of total adverse events of the affected shoulder compared to a partial rotator cuff repair, which were reported to be mostly mild to moderate in severity. Please note that complications reported by InSpace and Partial Repair patients were reviewed by a group of experts in shoulder surgery, and it was determined that none were related to the treatment devices (i.e., the InSpace Implant or devices used for Partial Repair). There is evidence of increased adverse events associated with a serious risk of the index shoulder which includes both medical and surgical treatments. The InSpace Implant is not fixed in place and may change position in the shoulder space. Movement out of the subacromial space and/or deflation of the InSpace Implant was observed in magnetic resonance imaging (MRI) 6 weeks post-operatively in up to half of patients. In these cases, it should be noted that no re-operations were required to remove the InSpace Implant.

The risks and benefits of the InSpace Implant in patients with the following conditions should be carefully considered: severe arthritis in the shoulder or full thickness cartilage loss, deltoid muscle defect or deltoid muscle paralysis, evidence that the shoulder is very unstable, missing or non-intact ligaments in the shoulder, known loss of sensation, major medical conditions such as blood clotting disorders, conditions that suppress the immune system or any other conditions that may compromise healing, safety and effectiveness of InSpace Implant use in patients below age sixty-five (65) has not been established, and safety and effectiveness of InSpace Implant use in pregnant or nursing mothers has not been evaluated.

If a reaction occurs, it will require follow-up with your surgeon. Some examples are as follows: irritation at the site where a cut was made during surgery, local infection, inflammation, and tissue damage where the InSpace Implant was implanted, or worsening of an existing infection. Additionally, movement of the implant out of its intended location may lead to worsening of your shoulder pain, discomfort, and/or stiffness which may require a re-operation, narcotic medications, non-narcotic pain medications, or post-operative shoulder injections.

As with any surgery, your surgical procedure may cause complications or adverse events. As with any shoulder surgery involving anesthesia there are potential risks and complications, including dizziness, fainting, difficulty breathing, wound infection, wound drainage, swelling, local pain, bleeding, bruising, surgical wound opening, nerve pain or injury which could result in partial or complete loss of movement in your affected arm, tendon injury, loss of sensation in your skin and muscle around your surgical site, inflammation of the tissues that surround your rotator cuff joint, a frozen rotator cuff (inability to freely move the shoulder joint) and delayed wound healing. There is a risk that a deep vein clot will form (thrombosis) and travel to the lung (pulmonary embolism), which could lead to stroke, heart damage or death. Any of the aforementioned complications/risks could require treatment such as medicine or additional surgery that may involve replacing or removing your InSpace Implant dependent on timeframe as the implant is biodegradable.

The information presented is for educational purposes only. Speak to your doctor to decide if you are interested in learning more about the InSpace Implant. Individual results vary and not all patients will receive the same postoperative activity level. It is important to follow your surgeon’s advice regarding after surgery care (for example, physical therapy) as well as which immediate activities you may or may not perform after receiving the InSpace Implant. Not following this advice may cause complications with the InSpace Implant. Some complications may require you to have additional surgery. Ask your doctor if the InSpace Implant is right for you.

Stryker Corporation or its other divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: InSpace, Stryker, Together with our customers, we are driven to make healthcare better. All other trademarks are trademarks of their respective owners or holders.

IMPORTANT INFORMATION ABOUT SHOULDER REPLACEMENT

Shoulder Surgery

Reverse total shoulder joint replacement is intended for use in individuals with a functional deltoid muscle, grossly deficient rotator cuff, and pain disabled by one or more of the following: non-inflammatory degenerative joint disease (i.e. osteoarthritis) and avascular necrosis; pseudoparalysis or anterior superior escape; rotator cuff tear; correction of functional deformity; post-traumatic arthritis; revisions or fractures of the humeral head where adequate fixation can be achieved and adequate bone stock remains.

Shoulder joint replacement surgery is not appropriate for patients with certain types of infections, any mental or neuromuscular disorder which would create an unacceptable risk of device stability, device fixation failure or complications in postoperative care. Additionally, shoulder joint replacement surgery is not appropriate for patients whose anticipated activities would impose high levels of stress on the shoulder.

Like any surgery, shoulder replacement surgery has potential risks. Some may occur during surgery, such as bleeding, bone fracture, injury to nearby blood vessels or nerves, or other surgical or anesthesia-related complications. Other risks may occur during or after surgery and can include pain or stiffness, infection, blood clots, changes in blood pressure or heart rhythm, lung problems such as pneumonia or emboli, stroke or heart attack, and death. Implant related risks which may lead to a revision or removal of the implant include dislocation of the implant, loosening or wear of the implant, bone fracture, nerve damage, heterotopic bone formation (abnormal bone growth in tissue), wear or breakage of the implant, metal and/or foreign body sensitivity, soft tissue imbalance, osteolysis (localized progressive bone loss), audible sounds during motion, and reaction to particle debris. Being overweight, manual labor activities, some sports activities, patient age, activity level, certain medical conditions, alcohol or drug addiction, and mental disorders may be associated with increased risks.

Shoulder joint implants may not provide the same feel or performance characteristics experienced with a normal healthy joint. The information presented is for educational purposes only. Stryker is not dispensing medical advice. Please speak to your doctor to decide if shoulder joint replacement surgery is appropriate for you. Only your doctor can make the medical decision about which products and treatments are right for your own individual condition.

As with any surgery, joint replacement carries certain risks. Your surgeon will explain all the possible complications of the surgery, as well as side effects. Additionally, the lifetime of a joint replacement is not infinite and varies with each individual. Also, each patient will experience a different post-operative activity level, depending on their own individual clinical factors. Your doctor will help counsel you about how to best maintain your activities to potentially prolong the lifetime of the device. It is important to closely follow your doctor's instructions regarding post-surgery activity, treatment and follow-up care.

Stryker Corporation or its other divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Mako, AccuStop, Stryker. All other trademarks are trademarks of their respective owners or holders.


1000904124 Rev A

Please upgrade your internet browser.

Our website was designed for a range of browsers. However, if you would like to use many of our latest and greatest features, please upgrade to a modern, fully supported browser.

Find the latest versions of modern supported browsers »

Note: If you are browsing in Internet Explorer 9 or later, and you are still seeing this message, you may be in Compatability Mode. Look for the Compability View icon in your Address bar, or the Compatability View and Compatability View settings from the Tools Menu in your Internet Explorer toolbar (hit the ALT key if your menu bar is hidden). If you are on an Intranet, you may need to contact your IT Support about Compatability View settings and whitelists.